Dr. Reddy's Laboratories Limited (NSE:DRREDDY)
India · Delayed Price · Currency is INR 1,211.20
-13.20 (-1.08%)
Jul 17, 2026, 3:29 PM IST
Dr. Reddy's Laboratories Stock Forecast
Stock Price Forecast
According to 39 analysts polled by S&P Global, Dr. Reddy's Laboratories stock has a consensus rating of "Hold" and an average price target of ₹1,333. The average 1-year stock price forecast is 10.09% higher than the current stock price, while the lowest is ₹1,040 (-14.13%) and the highest is ₹1,750 (+44.48%).
Price Target: ₹1,333 (+10.09%)
Analyst Consensus: Hold
Price Target
Chart* Price targets were last updated on Apr 23, 2026.
Analyst Ratings
The average analyst rating for Dr. Reddy's Laboratories stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 12 | 11 | 12 | 12 | 12 |
| Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Hold | 11 | 10 | 10 | 10 | 10 | 10 |
| Sell | 7 | 7 | 7 | 6 | 6 | 6 |
| Strong Sell | 5 | 5 | 6 | 6 | 6 | 6 |
| Total | 38 | 38 | 38 | 39 | 39 | 39 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Sell Downgrades ₹1,075 | Sell | Downgrades | ₹1,075 | -11.25% | Apr 23, 2026 |
Unknown Analyst Geojit Research No rating | Geojit Research | Hold Maintains ₹1,390 | Hold | Maintains | ₹1,390 | +14.76% | Feb 24, 2026 |
Financial Forecast
Revenue This Year
355.89B
from 335.93B
Increased by 5.94%
Revenue Next Year
394.62B
from 355.89B
Increased by 10.88%
EPS This Year
50.57
from 55.39
Decreased by -8.70%
EPS Next Year
63.65
from 50.57
Increased by 25.87%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.